These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24305700)

  • 41. The metabotropic glutamate (mGLU)2/3 receptor antagonist LY341495 [2S-2-amino-2-(1S,2S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic acid] stimulates waking and fast electroencephalogram power and blocks the effects of the mGLU2/3 receptor agonist ly379268 [(-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate] in rats.
    Feinberg I; Schoepp DD; Hsieh KC; Darchia N; Campbell IG
    J Pharmacol Exp Ther; 2005 Feb; 312(2):826-33. PubMed ID: 15383637
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interactions between the mGluR2/3 agonist, LY379268, and cocaine on in vivo neurochemistry and behavior in squirrel monkeys.
    Bauzo RM; Kimmel HL; Howell LL
    Pharmacol Biochem Behav; 2009 Nov; 94(1):204-10. PubMed ID: 19703487
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glyoxalase 1 and its substrate methylglyoxal are novel regulators of seizure susceptibility.
    Distler MG; Gorfinkle N; Papale LA; Wuenschell GE; Termini J; Escayg A; Winawer MR; Palmer AA
    Epilepsia; 2013 Apr; 54(4):649-57. PubMed ID: 23409935
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuroprotective effect caused by MPEP, an antagonist of metabotropic glutamate receptor mGluR5, on seizures induced by pilocarpine in 21-day-old rats.
    Jesse CR; Savegnago L; Rocha JB; Nogueira CW
    Brain Res; 2008 Mar; 1198():197-203. PubMed ID: 18242586
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synergistic action of CB
    Colangeli R; Di Maio R; Pierucci M; Deidda G; Casarrubea M; Di Giovanni G
    Neurobiol Dis; 2019 May; 125():135-145. PubMed ID: 30716469
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of the mGluR2/3 agonist LY379268 on ketamine-evoked behaviours and neurochemical changes in the dentate gyrus of the rat.
    Imre G; Salomons A; Jongsma M; Fokkema DS; Den Boer JA; Ter Horst GJ
    Pharmacol Biochem Behav; 2006 Jul; 84(3):392-9. PubMed ID: 16857251
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metabotropic glutamate receptors and neuroadaptation to antidepressants: imipramine-induced down-regulation of beta-adrenergic receptors in mice treated with metabotropic glutamate 2/3 receptor ligands.
    Matrisciano F; Scaccianoce S; Del Bianco P; Panaccione I; Canudas AM; Battaglia G; Riozzi B; Ngomba RT; Molinaro G; Tatarelli R; Melchiorri D; Nicoletti F
    J Neurochem; 2005 Jun; 93(5):1345-52. PubMed ID: 15934953
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuroprotective effects of thromboxane receptor antagonist SQ 29,548 after pilocarpine-induced status epilepticus in mice.
    Mello FK; Freitas ML; Souto NS; Zorzi VN; Moreira MP; Neuberger B; Costa KG; Fighera MR; Royes LF; Furian AF; Oliveira MS
    Epilepsy Res; 2020 Feb; 160():106277. PubMed ID: 32036236
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Attenuation of methamphetamine seeking by the mGluR2/3 agonist LY379268 in rats with histories of restricted and escalated self-administration.
    Kufahl PR; Watterson LR; Nemirovsky NE; Hood LE; Villa A; Halstengard C; Zautra N; Olive MF
    Neuropharmacology; 2013 Mar; 66():290-301. PubMed ID: 22659409
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The mGluR
    Sokolenko E; Hudson MR; Nithianantharajah J; Jones NC
    J Psychopharmacol; 2019 Dec; 33(12):1588-1599. PubMed ID: 31580222
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacological stimulation of group ii metabotropic glutamate receptors reduces cocaine self-administration and cocaine-induced reinstatement of drug seeking in squirrel monkeys.
    Adewale AS; Platt DM; Spealman RD
    J Pharmacol Exp Ther; 2006 Aug; 318(2):922-31. PubMed ID: 16675638
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biphenyl-indanone A, a positive allosteric modulator of the metabotropic glutamate receptor subtype 2, has antipsychotic- and anxiolytic-like effects in mice.
    Galici R; Jones CK; Hemstapat K; Nong Y; Echemendia NG; Williams LC; de Paulis T; Conn PJ
    J Pharmacol Exp Ther; 2006 Jul; 318(1):173-85. PubMed ID: 16608916
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activation of mGlu3 metabotropic glutamate receptors enhances GDNF and GLT-1 formation in the spinal cord and rescues motor neurons in the SOD-1 mouse model of amyotrophic lateral sclerosis.
    Battaglia G; Riozzi B; Bucci D; Di Menna L; Molinaro G; Pallottino S; Nicoletti F; Bruno V
    Neurobiol Dis; 2015 Feb; 74():126-36. PubMed ID: 25434487
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The selective group mGlu2/3 receptor agonist LY379268 suppresses REM sleep and fast EEG in the rat.
    Feinberg I; Campbell IG; Schoepp DD; Anderson K
    Pharmacol Biochem Behav; 2002 Sep; 73(2):467-74. PubMed ID: 12117602
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The glutamatergic compounds sarcosine and N-acetylcysteine ameliorate prepulse inhibition deficits in metabotropic glutamate 5 receptor knockout mice.
    Chen HH; Stoker A; Markou A
    Psychopharmacology (Berl); 2010 May; 209(4):343-50. PubMed ID: 20217053
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-epileptic activity of group II metabotropic glutamate receptor agonists (--)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268) and (--)-2-thia-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY389795).
    Moldrich RX; Jeffrey M; Talebi A; Beart PM; Chapman AG; Meldrum BS
    Neuropharmacology; 2001 Jul; 41(1):8-18. PubMed ID: 11445181
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of the mGluR2/3 agonist LY379268 and the mGluR5 antagonist MPEP on handling-induced convulsions during ethanol withdrawal in mice.
    Olive MF; Becker HC
    Alcohol; 2008 May; 42(3):191-7. PubMed ID: 18420113
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The group II metabotropic glutamate receptor agonist, LY379268, decreases methamphetamine self-administration in rats.
    Crawford JT; Roberts DC; Beveridge TJ
    Drug Alcohol Depend; 2013 Oct; 132(3):414-9. PubMed ID: 23953655
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The preclinical properties of a novel group II metabotropic glutamate receptor agonist LY379268.
    Imre G
    CNS Drug Rev; 2007; 13(4):444-64. PubMed ID: 18078428
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional role of mGluR1 and mGluR4 in pilocarpine-induced temporal lobe epilepsy.
    Pitsch J; Schoch S; Gueler N; Flor PJ; van der Putten H; Becker AJ
    Neurobiol Dis; 2007 Jun; 26(3):623-33. PubMed ID: 17446080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.